CTOs on the Move

Well Dot

www.well.co

 
Indico is the leading provider of Intelligent Process Automation (IPA) solutions. We help organizations turn process into profit by enabling them to automate manual, labor-intensive, document-based workflows.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.well.co
  • 186 South Street Ste 400
    Boston, MA USA 02111
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Well Dot raised $22M on 12/14/2020
Well Dot raised $40M on 12/14/2020
Well Dot raised $71.8M on 04/08/2022

Similar Companies

eVapt

eVapt is a Austin, TX-based company in the Software and Internet sector.

MetraTech

MetraTech Corp. is a Waltham, MA-based company in the Software and Internet sector.

Novisync solutions

Novisync solutions is a Fishkill, NY-based company in the Software and Internet sector.

Royal Jay

Royal Jay LLC is a proven, results-driven, technology company that creates innovative software products. Though we are a small (9 of us!), we have all the benefits and perks you would expect from a large company including health, retirement and a very competitive compensation package. As a small team we are able to focus on what matters, creating a great culture. At Royal Jay you’ll work with the best tech and tools, on challenging work, in a great environment where your contributions and strengths are recognized and rewarded. We work hard and play hard, while making sure our team is happy, healthy & financially secure. If you are driven by technology and love to code, we want to work with you. We are located in Boise, ID, A clean, safe city with a low cost of living ideal for families, outdoor enthusiasts and entrepreneurs.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.